Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation
Clinical Cardiology · 2026
DOI: 10.1002/clc.70469 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Cardiology, 2026. Verfasst von Yanxin Han und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pulmonary Veins, Vena Cava, Superior, Cryosurgery. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The superior vena cava (SVC) is a common non‐pulmonary vein (non‐PV) trigger site in atrial fibrillation (AF), but its triggers are frequently underdetected without systematic mapping and provocation maneuvers. This study aimed to assess the temporal trend in SVC trigger detection rates and compare the efficacy and safety of cryoballoon‐based targeted SVC isolation combined with pulmonary vein isolation (PVI) versus PVI alone.
Methods
A retrospective analysis was conducted on 990 consecutive patients who underwent cryoballoon ablation for AF between January 2020 and December 2024. Annual SVC trigger detection rates were assessed using the Cochran‐Armitage trend test. After excluding redo cases and performing 1:1 propensity score matching, 55 matched pairs were compared in terms of procedural outcomes, complications, and 12‐month freedom from atrial tachyarrhythmias.
Results
SVC trigger detection rates increased significantly over the study period, from 6.8% in 2020 to 21.3% in 2024 (P for trend = 0.023). After matching, the PVI + SVCI group showed significantly higher 12‐month freedom from atrial tachyarrhythmias compared to the PVI‐only group (90.9% vs. 76.4%, p = 0.037). Procedural time was modestly longer in the PVI + SVCI group (93 ± 26 min vs. 80 ± 20 min, p = 0.003), but fluoroscopy time (12 ± 5 min vs. 10 ± 4 min, p = 0.276) and complication rates (5.5% vs. 3.6%, p = 0.500) were comparable between groups, both with low overall complication rates.
Conclusion
Cryoballoon‐based targeted SVC isolation guided by systematic mapping and provocation maneuvers significantly enhances freedom from atrial tachyarrhythmias without compromising safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Yangyang Bao, Yun Xie, Qi Jin, Liqun Wu
Zitieren
APA
Han, Y., Bao, Y., Xie, Y., Wei, Y., Luo, Q., Ling, T., Pan, W., Zhang, N., Jin, Q., Lin, C., & Wu, L. (2026). Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation. Clinical Cardiology. https://doi.org/10.1002/clc.70469
Vancouver
Han Y, Bao Y, Xie Y, Wei Y, Luo Q, Ling T, et al. Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation. Clinical Cardiology. 2026. doi:10.1002/clc.70469
BibTeX
@article{Han2026,
author = {Han, Yanxin and Bao, Yangyang and Xie, Yun and Wei, Yue and Luo, Qingzhi and Ling, Tianyou and Pan, Wenqi and Zhang, Ning and Jin, Qi and Lin, Changjian and Wu, Liqun},
title = {Targeted Superior Vena Cava Isolation Combined With Pulmonary Vein Isolation Versus Pulmonary Vein Isolation Alone Using Cryoballoon Ablation for Atrial Fibrillation},
journal = {Clinical Cardiology},
year = {2026},
doi = {10.1002/clc.70469}
}
EUVIMED